Celltrion
068270 · KRX · Health Care · Biotechnology and Biosimilars
About the company
Celltrion is a South Korean biopharmaceutical company that develops, manufactures, and commercializes biosimilar medicines targeting major autoimmune and oncology conditions. It is one of the largest biosimilar producers globally and sells its products in the United States, Europe, and Asia through its commercialization subsidiary Celltrion Healthcare. The company operates large-scale mammalian cell culture manufacturing facilities in Incheon.
| Exchange | KRX |
| Ticker | 068270 |
| Sector | Health Care · Biotechnology and Biosimilars |
| Indicative market cap USD | $38.00B |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
On its home market (KRX), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Korea Exchange, which operates the KOSPI Market for large-cap equities, the KOSDAQ Market for growth and technology companies, and a Derivatives Market division. — official exchange listing
Availability information only. Not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in South Korea
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only. Not investment advice. Verify with the exchange, the company's filings and your broker.